CSL Seqirus’ Audenz is among the three avian flu vaccines that make up US stockpiles. The company describes Audenz, which the FDA approved in 2020, as "the first-ever adjuvanted, cell-based influenza ...

Manufacturing an emergency pandemic flu vaccine would likely involve GSK, Sanofi, and CSL Seqirus, foreign companies with U.S. manufacturing plants that are all suppliers of the annual flu vaccine.

CSL Seqirus is able to produce large quantities of avian flu vaccine in addition to the traditional annual influenza vaccine because its pandemic offering utilizes the same components and the same ...

Additionally, the Holly Springs site is the largest cell-based flu vaccine manufacturing site in the world. Preventing the spread of influenza on a global scale is CSL Seqirus' primary mission ...

Both the Finnish and the U.S. bird flu vaccines are made by CSL Seqirus but are different vaccines. In the summer, U.S. officials stockpiled 4.8 million doses of the vaccine that officials said was ...

CSL Seqirus has agreed to provide 665,000 doses of a bird flu vaccine to the European Commission as part of the EU’s efforts to prepare for a potential outbreak of the disease, with an option to ...

I maintain a Neutral view on CSL Limited due to the mixed prospects for its flu vaccine (Seqirus) and plasma therapy (Behring ...

You can have fever, muscle aches, tiredness and end up in bed for a number of days,” adds Dr Julianne Bayliss, CSL Seqirus Vaccines ... need to know about the flu vaccine, including when is ...

CSL Seqirus has production facilities in the United ... Moderna’s mRNA-based bird flu vaccine mRNA-1018 is undergoing a Phase 1/2 study targeting H5 and H7 avian influenza viruses.